Form 4 for ALT Altimmune, Inc.
Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-25 · accession 0001104659-25-006841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-28 | 2025-01-25 | ALT | Harris Matthew Scott | Chief Medical Off | F - Tax | $6.98 | -4,994 | 64.7K | -7% | -$34.9K |
| D | 2025-01-28 | 2025-01-25 | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | +14.6K | 69.7K | +26% | $0 |
| D | 2025-01-28 | 2025-01-25 | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | +14.6K | 43.8K | +50% | $0 |
| DM | 2025-01-28 | 2025-01-27 | ALT | Harris Matthew Scott | Chief Medical Off | A - Grant | $0.00 | +247.0K | 63.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2025-01-25 | F | D | 4,994 | $6.98 | 64,725 | D | — | — | |
| 2 | Common | Common Stock, par value $0.0001 | 2025-01-25 | M | A | 14,600 | $0.00 | 69,719 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. |
| 3 | Derivative | Restricted Stock Units | 2025-01-25 | M | A | 14,600 | $0.00 | 43,800 | D | — · — to — | 14,600 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |
| 4 | Derivative | Stock Options (option to buy) | 2025-01-27 | A | A | 183,600 | $0.00 | 183,600 | D | $7.00 · — to 2035-01-27 | 183,600 Common Stock, par value $0.0001 | (F4) Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date. |
| 5 | Derivative | Restricted Stock Units | 2025-01-27 | A | A | 63,400 | $0.00 | 63,400 | D | — · — to — | 63,400 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |